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uantification of Absolute Myocardial Blood
low by Magnetic Resonance Perfusion Imaging
aniel C. Lee, MD, Nils P. Johnson, MD
hicago, Illinois
y serially imaging the myocardium during the initial transit of gadolinium contrast, magnetic resonance
erfusion imaging can accurately assess relative reductions in regionalmyocardial blood flowand identify
emodynamically significant coronary artery disease. Models can be used to quantify myocardial blood
ow (in milliliters/minute/gram) on the basis of dynamic signal changes within the myocardium and left
entricular cavity. Although themathematical modeling involved in this type of analysis adds complexity,
he benefits of absolute blood flow quantification might improve clinical diagnosis and have important
mplications for cardiovascular research. (J Am Coll Cardiol Img 2009;2:761–70) © 2009 by the American
ollege of Cardiology Foundations
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de Mlthough coronary angiography remains the
tandard for diagnosing coronary artery dis-
ase (CAD), visual estimates of stenosis se-
erity and hemodynamic significance remain
mperfect (1). Intracoronary assessments of
ressure gradients and flow reserve involve
reater procedural risk and higher cost than
oninvasive techniques.
Positron emission tomography (PET) has
raditionally been the noninvasive standard for
uantitative measurements of absolute myocar-
ial blood flow (AMBF) in milliliters/minute/
ram. Measurements at stress and rest have
een reported in normal individuals, and re-
uctions in myocardial perfusion reserve
MPR) have been demonstrated in patients
ith CAD risk factors (2). However, wide-
pread clinical application has been slowed by
imited access to cardiac PET cameras and
rom the Feinberg Cardiovascular Research Institute, Departme
ardiovascular Institute, Feinberg School of Medicine, Northwe
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ng also involves exposure to ionizing radiation,
nd the low spatial resolution limits evaluation
f transmural flow differences in normal thick-
ess myocardium.
Single-photon emission computed tomogra-
hy images are scaled to the most intense area
f uptake in the ventricle, enabling assessment
f relative perfusion but not absolute perfusion
r MPR. AMBF quantification is possible with
ynamic single-photon emission computed to-
ography imaging (3), but cameras with suf-
cient speed and count sensitivity are not
idely available. Myocardial contrast echocar-
iography enables real-time, bedside measure-
ent of parameters reflecting blood velocity
nd blood volume, the product of which pro-
ides an index of perfusion and MPR (4).
owever, the quality of regional intensity time
f Medicine and Division of Cardiology, Bluhm
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762ourses might be compromised by limited windows
r shadowing from blood signal, and obtaining an
rterial input function suitable for modeling re-
ains difficult. Computed tomography perfusion
an quantify AMBF (5) with models similar to
hose described in the following text. Limitations
nclude the need for both ionic contrast and radia-
ion exposure in addition to modality-specific arti-
acts due to beam hardening.
Cardiac magnetic resonance perfusion imaging
CMR-PI) can quantify AMBF in milliliters/
inute/gram. Some advantages of CMR-PI in-
lude its lack of ionizing radiation, the wide avail-
bility of CMR imaging systems, and a sufficiently
igh spatial resolution to allow analysis of transmu-
al differences in myocardial blood flow. This article
will begin by briefly reviewing the steps
involved in acquiring CMR-PI studies
and the clinical performance of qualitative
and semiquantitative analysis of CMR-PI
studies. The majority of this article will
focus on the theory and experimental re-
sults supporting CMR-PI quantification
of AMBF.
CMR-PI Acquisition
Most CMR-PI studies are performed in a
clinical 1.5-T magnet with phased array
receiver coils placed on the chest and back.
The heart is imaged every cardiac cycle
during the passage of an intravenous bolus
of a gadolinium-based contrast agent
(GdCA). Because gadolinium is a para-
magnetic compound that decreases T1
relaxation times, regional delivery of
GdCA-rich blood results in a progressive
ncrease in signal intensity on T1-weighted pulse
equences. Areas receiving impaired blood flow and
onsequently less GdCA appear darker than nor-
ally perfused areas (Fig. 1). Imaging during phar-
acologic vasodilation with adenosine or dipyri-
amole is routinely performed to improve the
ifferentiation of normal from stenotic perfusion
eds. A typical clinical perfusion study also includes
esting cine and late gadolinium enhanced (LGE)
mages. Cine CMR provides reproducible, high-
esolution assessment of cardiac mass, volume, and
unction. LGE accurately defines the location and
xtent of acute and chronic infarction and predicts
he likelihood of wall motion recovery after revas-
ularization (6). Imaging time for a full study is
l
m
se
ncedpproximately 50 min. sualitative and Semiquantitative Analysis
he simplest method for interpreting CMR-PI
tudies is to view the study in cine-loop format for
egions of relative hypoperfusion. Numerous single
enter studies demonstrate high diagnostic accuracy
hen qualitative interpretation of clinical CMR-PI
tudies is compared with invasive angiography (7).
Figure 1 depicts semiquantitative analysis of a
MR-PI study, which examines the mean signal
ntensity within a region of interest over time, or
time intensity curve” (TIC). Measurements such as
he maximum upslope or initial area under the TIC
ave been used as indexes of regional flow (8). In
nimals these indexes have been shown to correlate
ell with flow measurements based on injected
icrospheres (9,10). Semiquantitative analysis has
een shown to improve diagnostic accuracy over
isual analysis alone (11).
Early results regarding the prognostic value of
MR-PI indicate that patients with an abnormal
erfusion study have a higher incidence of cardiac
eath or nonfatal myocardial infarction than those
ith a normal scan, and patients with a normal scan
ave an annual hard event rate of 1% per year
12)—similar to the prognosis of a normal radio-
uclide perfusion scan (13).
bsolute Perfusion Quantification
n contrast to semiquantitative methods, models
xist that quantify AMBF. These are similar in
erivation to those employed in quantitative PET
nd computed tomography perfusion as well as
hermodilution estimation of cardiac output. Flow
odels use the myocardial and left ventricular (LV)
lood pool TICs to estimate AMBF. Although a
etailed mathematical description of these flow
odels is beyond the scope of this review, some
nderstanding of their assumptions and limitations
an guide their appropriate application. Two major
lasses of models exist: linear, shift-invariant (LSI)
odels and compartment models. Each class of
odel has its own assumptions that must hold or at
east approximately hold for the model to produce
eaningful and valid estimations of flow.
SI models. The LSI models have proved more
opular in CMR-PI than compartment models.
he LSI models assume the cardiac circulatory
ystem is linear and temporally invariant in its
esponse. In other words, if 2 contrast boluses are
njected, then the myocardial uptake is the linear
um of the uptake had each bolus been injectedB B R E V I A T I O N S
N D A C R O N YM S
MBF absolute myocardia
lood flow
AC coronary artery calciu
core
AD coronary artery disea
MR-PI cardiac magnetic
esonance perfusion imaging
FR fractional flow reserve
dCA gadolinium-based
ontrast agent
GE late gadolinium enha
SI linear, shift-invariant
V left ventricular
PRmyocardial perfusion
eserve
NR signal-to-noise ratioeparately; and if the injection of a bolus is delayed
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763y a certain amount of time, then its uptake is
elayed (shifted) by the same amount of time.
hese 2 assumptions allow for a powerful and
omplete description of the system by its so-called
transfer function.” Characteristics of the transfer
unction reflect properties of its system, the most
elevant of which is AMBF.
The output from an LSI system (the myocardial
IC) is equal to the input to the system (the tracer
olus, measured from the LV TIC) merged with
he transfer function by a mathematical process
nown as convolution (Fig. 2). Convolution folds 2
urves together via a shift-scale-and-add process
imilar to cross-correlation in statistics. To obtain
he transfer function, the input and output curves
ust undergo the reverse process of deconvolution.
nfortunately the process of deconvolution is very
ensitive to noise, so that small errors in the input
ata can lead to large differences in the resulting
ransfer function. Therefore, additional constraints
eed to be imposed to obtain a physiologic solution.
The most popular method for “constrained” de-
onvolution demands that the transfer function take
certain shape. This curve can be described by 4
Figure 1. CMR-PI Acquisition and Semiquantitative Analysis
The heart is imaged every cardiac cycle during the ﬁrst passage of
stack can be viewed in cine-loop format for qualitative assessment
suring the mean signal intensity over time for a region of interest a
of regional ﬂow. Adapted with permission from Lee et al. (54). CMR
electrocardiogram.arameters and is known as the Fermi function (14) dFig. 2). It can be shown that the maximum value of
he Fermi transfer function equals AMBF (15).
ote that the Fermi function builds in a delay
efore its upstroke to allow for passage of the
ontrast from the left ventricle into the coronary
rteries before perfusing the tissue.
The validity of deconvolution depends most im-
ortantly on the assumption of linearity. Both the
nput (signal in the LV blood pool) and output
signal in the myocardium) must behave in the same
inear fashion with the concentration of tracer. To
aximize the signal-to-noise ratio (SNR) in the
yocardium, a large gadolinium bolus is preferred.
owever, at clinically desired myocardial signals,
he linear range of the CMR signal response within
oth the blood pool and myocardium has already
een exceeded.
This nonlinear effect within the LV blood pool
as been appreciated for many years. Two tech-
iques have been proposed to preserve both high
yocardial SNR and linear blood pool signal re-
ponse. The dual-T1 sensitivity technique (16) ac-
uires both low-resolution, low T1-sensitivity blood
ool and high-resolution, high T1-sensitivity myocar-
olinium-based contrast agent. The resulting 30- to 40-frame image
gional ﬂow deﬁcits. Semiquantitative ﬂow analysis involves mea-
calculating the peak upslope or area under the curve as an index
cardiac magnetic resonance perfusion imaging; ECG gad
of re
nd
-PI ial data within each R-R interval. The dual-bolus
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764echnique (17) injects 2 boluses, an initial minibolus
hat maintains blood pool linearity followed by a large
olus that maximizes myocardial SNR (18).
It had been assumed, because myocardial CMR
ignals were much less than blood pool signals, that
onlinearity was not an issue within the myocar-
ium. However, a growing body of evidence sug-
ests that myocardial nonlinearity becomes signifi-
ant at bolus concentrations necessary for sufficiently
igh myocardial SNR (19–21). This effect might be
ue to incomplete extraction of GdCA from the
ascular space, limiting the proportion of myocar-
ial protons with which gadolinium can interact.
he optimal solution to this nonlinearity has not
et been defined, although converting the CMR
ignal into gadolinium concentration (19,21) or
orrecting the signal with algorithms based on the
heoretical signal response to gadolinium (22,23)
ight be feasible options.
Another assumption in the LSI model is that the
nput function can be accurately measured. For con-
enience, the input TIC is taken from the LV blood
ool in the short axis. However, this bolus undergoes
urther mixing and dispersion before reaching the
oronary arteries, a phenomenon better appreciated in
uantitative cerebral perfusion (24). Additionally, the
resence of collateral flow alters the input function
een by a region of myocardium (25). These effects
eed to be minimized or accounted for when specify-
ng the input time-intensity curve.
The specific validity of the Fermi deconvolution
Figure 2. AMBF Calculation by Fermi Function Deconvolution
Myocardial time intensity curve (TIC) (left-most panel) equals the b
the Fermi transfer function (right-most panel). The maximum ampl
(AMBF). In this data from a dual-bolus study, the blood pool signal
factor of 10 on the basis of the gadolinium (Gd) concentration ratio
the dashed lines of the myocardial and blood pool TICs are used fo
then conversion to Gd concentration before deconvolution. A.U. odel is challenged by several deviations from its dssumptions. First, the tracer bolus recirculates, and
hus its “first-pass” contains some of the second-
ass as well. Although recirculation does not violate
he assumptions of an LSI system, it does demand
more complex transfer function than that offered
y the Fermi model. Alternatively, recirculation can
e modeled and subtracted from the time-intensity
urves to remove its effects (26). Second, most clini-
ally approved GdCA do not remain exclusively
ithin the intravascular space, but leak into extravas-
ular compartments. Again, this leak does not violate
SI assumptions, but the Fermi transfer function
annot accommodate it. Finally, the presence of col-
aterals requires a more complex shape to the transfer
unction than allowed by the Fermi model (25).
To overcome these limitations, a more complex
onstrained deconvolution model termed “model-
ndependent” (although it is itself a parameterized
odel) has been proposed (27). This builds a
ransfer function from splines and uses sophisti-
ated mathematical techniques to produce a more
ntricate curve while not overfitting noise within the
ata. However, its use has not become widespread,
ikely due to its mathematical complexity.
ompartment models. Compartment models divide
he cardiac circulatory system into distinct spaces
intravascular, interstitial, and intracellular). The
dCA concentration varies among these compart-
ents over time as molecules move from 1 space to
nother. Rate constants describe the movement
etween any 2 compartments (Fig. 3). Such models
pool TIC (middle panel) convolved with (“X” symbol in circle)
e of the transfer function equals absolute myocardial blood ﬂow
nsity (SI) values from the minibolus have been magniﬁed by a
the mini and full bolus (0.005/0.05 mmol/kg). The areas between
alysis; these underwent correction for coil effects and baseline SI,
trary units.lood
itud
inte
of
r anetermine compartment concentrations and the
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765ndividual rate constants from the summed time-
ntensity curve of all compartments (28).
Current Food and Drug Administration-
pproved GdCAs leak from the intravascular com-
artment into the interstitial compartment along an
smotic gradient but do not enter the intracellular
ompartment. Thus, a 2-compartment model (in-
ravascular and interstitial) has been used to model
ts transit through the cardiac circulatory system
19). The solution to the differential equations
escribing this 2-compartment model also produces
convolution relationship. In this case, the transfer
unction is an exponential decay. There are 2
arameters to the 2-compartment model’s transfer
unction. Unlike the LSI model, for which the
aximum amplitude of its transfer function is equal
o AMBF, the maximum amplitude of the
-compartment model transfer function is equal to
he product of AMBF and the myocardial extrac-
ion efficiency of the contrast agent. Their product
s labeled “k1” (the first-order rate constant) by
any authors when reporting their results. If the
xtraction efficiency is known or can be estimated,
hen AMBF alone can be determined. However,
his adds an extra assumption to the model for
uantifying perfusion. Thus, an advantage of the
SI model is that AMBF can be calculated explic-
tly, provided the transfer function can account for
he extravascular leakage of contrast (e.g., model
ndependent). The 2-compartment model also de-
ends on linearity of signal response, so the previ-
us comments about ensuring linearity in the blood
ool and myocardium apply as well.
alidation of Absolute Perfusion
y CMR-PI in Animal Models
everal studies have evaluated perfusion in instru-
ented animals to compare noninvasive AMBF by
MR-PI (17,18,21,27,29) with flow measured by
njected microspheres, which provide a pathologic
old standard for regional tissue perfusion (30). Syn-
hesizing the results from these studies is somewhat
ifficult because of important differences in CMR
ulse sequence, bolus strategy, quantitative model, and
pplication of myocardial signal nonlinearity correc-
ion (Table 1). Averaging adjacent slices (27) or restrict-
ng analysis to stenotic and remote zones (excluding
ectors in shoulder regions) (17,29) might also reduce
rrors of registration between CMR and microsphere
ow. Methodological differences notwithstanding, the
verall correlation between CMR and microsphere
MBF is good to excellent, with the correlation coeffi- eient ranging from 0.79 to 0.95 over a wide range of
yocardial blood flows. Additionally, absolute perfusion
orrelated more closely with microsphere blood flow
han established semiquantitative CMR indexes. When
he same signal intensity–time curves were analyzed to
alculate the peak enhancement ratio, upslope index, and
rea under the curve, these indexes plateaued at higher
lood flows, resulting in significant underestimation of
icrosphere flow values (17).
The existing body of experimental published data
n which AMBF by CMR-PI with LSI models and
icrospheres are compared in milliliters/minutes/
ram is still rather limited (total number of analyzed
egments 388) (Table 1). Also, lack of consensus on
ptimal acquisition and analysis techniques limits
road application at the present time.
Additional studies employing LSI models have
hown a good correlation between CMR and
icrosphere-determined MPR but did not report
MBF (31,32). Experimental studies using a com-
artment model have also demonstrated a linear
elationship between k1 and microsphere-derived
MBF over a flow range of 1 ml/min/g (r 
.88) (33), but changes in extraction efficiency at
igher flow rates might affect this relationship.
bsolute Perfusion Quantification
n Normal Volunteers
nderstanding AMBF in normal individuals is
Blood
Plasma
Extracellu
Space
‘Trapping
Figure 3. Diagram of a 3-Compartment Model
Divisions are illustrated for the blood plasma (p), extracellular space
a trapped intracellular space (trap). Cp(t), Ce(t), and Ctrap(t) represen
gadolinium (Gd) concentration change over time in each compartm
K1, K2, K3, K4 represent the transfer rate of Gd between compartme
(reprinted with permission from Fig. 1 of Knowles et al. [56]).lar
’
(e), and
t the
ent, and
ntsssential for appropriate evaluation of disease states.
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766esting and vasodilated AMBF have been evalu-
ted by CMR-PI in small cohorts of healthy vol-
nteers (Table 2) (34,35). Overall, CMR-PI
MBF measurements are in agreement with pub-
ished values based on invasive (36) and noninvasive
ethods (2), and the magnitude of flow heteroge-
eity (34) is similar to that seen in PET (37).
bsolute Perfusion Quantification in Patients With
picardial Coronary Artery Stenoses
nvestigators have begun to explore whether the
mproved accuracy of AMBF over qualitative and
emiquantitative techniques demonstrated in ani-
al models would translate to patients with sus-
ected CAD undergoing coronary angiography
38). An MPR cutoff of 2.04 was 93% sensitive and
7% specific in predicting intracoronary fractional
ow reserve (FFR) 0.75 and 85% sensitive and
9% specific in predicting 50% diameter stenosis
y quantitative coronary angiography. The authors
uggested that low specificity might be due to
icrovascular dysfunction causing low MPR in
egments with preserved FFR or low diameter
tenosis. In the same group of patients, quantitative
PR performed better than semiquantitative or
isual techniques (39). The optimal MPR cutoff
alue is higher than cutoff values derived from
revious studies of relative perfusion (40), which
xperimental Studies Comparing AMBF by CMR-PI and Injected M
Year (Ref. #) CMR-PI Studies # of Sectors
GdCA Bolus
(mmol/kg)
rold, 2002 (27) 5 studies (3 pigs) 30–40 Single (0.04)
003 (29) 24 studies (12 pigs) 46 Single (0.03)
004 (17) 16 studies (16 dogs) 96 Dual (0.0025/0.
(21)* 14 studies (4 dogs) 84 Dual (0.005/0.0
008 (18) 12 studies (6 dogs) 36 Dual (0.0025/0.
36 Single (0.025)
sity–time curves were converted to gadolinium concentration-time curves befor
solute myocardial blood ﬂow; CMR-PI  cardiac magnetic resonance perfusion im
le shot; SR-EPI  saturation recovery gradient-echo with echo-planar readout.
Table 2. AMBF by CMR-PI Measured in Healthy Volunteers
Author, Year
(Ref. #)
Rest AMBF
(ml/min/g)
Stress AMBF
(ml/min/g)
Perfusion
Reserve
Muehling, 2004 (34) 1.1 0.4 4.2 1.1 4.1 1.4
Hsu, 2006 (35) 1.0 0.2 3.4 0.6 3.4 0.7aAbbreviations as in Table 1.ight be due to underestimation of AMBF at
igher flow rates by semiquantitative methods (17).
lobal Reductions in MPR
MBF might be particularly advantageous in pa-
ients with globally reduced MPR, because qualita-
ive or semiquantitative methods might be ham-
ered by the lack of a normal reference segment. In
atients with chest pain and without hemodynam-
cally significant coronary artery lesions (a.k.a. “Syn-
rome X”), a close linear correlation has been
hown between MPR by CMR-PI and intracoro-
ary flow reserve (15,32). In patients with hyper-
rophic cardiomyopathy, hyperemic AMBF was
ignificantly lower than in control subjects and
emained so even after adjusting for end-diastolic
all thickness (41). A stepwise reduction in MPR
nd endo/epicardial perfusion ratio was demon-
trated when comparing volunteers, transplant re-
ipients with no hypertrophy or prior rejection,
ransplant recipients with either hypertrophy or
rior rejection, and transplant recipients with trans-
lant arteriopathy (42).
Hyperemic AMBF and MPR have also been
hown to correlate inversely with risk factor burden
or coronary heart disease in a population-based
ohort of asymptomatic adults (43). When stratified
ccording to coronary artery calcium score (CAC),
ean resting AMBF did not differ across CAC
evels, but mean hyperemic AMBF and MPR were
rogressively lower across increasing CAC levels
44). A subset of these patients also underwent
agged cine CMR examination, demonstrating that
ower hyperemic MBF was associated with reduced
egional peak systolic circumferential strain in the
ight coronary artery and left circumflex coronary
spheres
AMBF Range
(ml/min/g)
Pulse
Sequence
Transfer
Function
Linear
Correlation
0.5–6 SR-FLASH Model independent y  0.96x  0.06
r  0.96
0–2.5 SR-FLASH Fermi function y  0.77x  0.11
r  0.79
0–5 SR-EPI Fermi function y  0.95x  0.1
r  0.95
0–4 SR-EPI Fermi function y  0.93x - 0.05
r  0.82
0.5–4.5 SR-EPI Fermi function r  0.94
r  0.91
convolution.
g; GdCA  gadolinium-based contrast agent; SR-FLASH  saturation recoveryTable 1. E icro
Author,
Jerosch-He
Mühling, 2
Christian, 2 1)
Lee, 2008 5)
Christian, 2 1)
*Signal inten e de
AMBF  ab aginrtery regions (45).
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767isease Progression/Response to Therapy
MBF might also be advantageous in monitoring
isease progression or perfusion changes in re-
ponse to therapy, because (unlike measurements of
elative regional perfusion) changes in the test and
emote regions can be considered separately. Be-
ause the limits of agreement between CMR-PI
nd microsphere AMBF are approximately  0.6
l/min/g (17), detection of individual changes in
esting or peri-infarction flow might not be possi-
le. However, detecting changes in vasodilated flow
ight be possible, and studies that have evaluated
roup differences in resting and vasodilated AMBF
re discussed in the following text.
The CMR-PI performed before and 6 weeks
fter implantation of a device designed to induce
ngiogenesis in pigs reported an increase in adeno-
ine vasodilated AMBF in the treated area, which
as not seen in sham animals (46). The AMBF
easured before and after transmyocardial laser
evascularization in a pig model of ischemia re-
orted preserved AMBF in transmyocardial laser
evascularization-treated animals but reduced
MBF in untreated animals (29).
In patients with hibernating myocardium, hiber-
ating segments had reduced resting AMBF before
ercutaneous coronary intervention (PCI), which
as lower than in remote segments. AMBF in-
reased in revascularized segments to levels compa-
able to remote segments after PCI, and improve-
ent in regional wall motion accompanied
ncreases in AMBF (47). In a study of patients with
MR evidence of distal embolization after PCI,
egments demonstrating new distal LGE had a fall
n MPR from the pre-PCI scan to 24 hours after
CI, whereas MPR in segments without LGE
ncreased. In patients who were scanned 6 months
ater, MPR in affected segments normalized (48).
Measurement repeatability importantly influ-
nces power calculations in studies attempting to
etect changes after an intervention. In 7 normal
olunteers and 9 patients with CAD undergoing
MR-PI, the coefficient of variation for global
PR was 21% for AMBF and 41% for semiquan-
itative upslope analysis (49). In 30 participants of
he MESA (Multi-Ethnic Study of Atherosclero-
is) study who underwent 2 CMR exams approxi-
ately 1 year apart, the absolute repeatability coef-
cient as a percentage of mean blood flow was 30%
t rest and 41% during hyperemia (50)—similar to
tudies of PET performed at rest (27% of mean)
51) and higher than PET values reported at stress d25% of mean) (52), although these PET studies
ere performed 1 h apart in a younger cohort with
igher vasodilated AMBF.
ubendocardium
he sensitivity for detecting limitations in myocar-
ial perfusion might be improved by measuring
ow in the subendocardium, where hemodynamic
actors and the impact of microvascular dysfunction
re more prominent (53). The high spatial resolu-
ion of CMR-PI has been used to assess the
radient in flow from endocardium to epicardium
54,55) (Fig. 4). With absolute perfusion tech-
iques, endocardial flow was reduced in comparison
ith epicardial flow in dog models of coronary
rtery stenosis (17,21). In healthy volunteers, mean
erfusion in the endocardium was significantly
igher than in the epicardium at rest but similar
uring stress (34). And in patients with hypertro-
hic cardiomyopathy, the likelihood of an endo-
yocardial/epimyocardial MBF ratio 1 during
yperemia increased with wall thickness (41).
atient Selection
ontraindications to CMR include certain im-
lanted medical devices (including pacemakers) and
edical conditions (unstable angina or New York
eart Association functional class IV heart failure).
dCA should not be administered to pregnant and
actating women or patients with severe renal dis-
ase (glomerular filtration rate 30 ml/min/1.73
2). Finally, the usual contraindications to adeno-
ine administration (advanced heart block, respira-
ory compromise) apply.
tudy Limitations and Future Directions
urther advancements need to continue both in
MR-PI acquisition and AMBF analysis. Most
ontemporary pulse sequences do not achieve full
eart coverage but can acquire at least 3 short-axis
lices every heart beat with an acquisition time of
pproximately 150 ms/slice and a spatial resolution
f2 mm. Faster pulse sequences, new acceleration
echniques, and imaging at higher field strengths
hould enable greater heart coverage, spatial reso-
ution, and/or contrast-to-noise ratio.
The AMBF models continue to be refined to
alance the complexity of the model against suscepti-
ility to noise. Direct comparisons of different analysis
chemes are beginning to emerge (18) and should help
efine the most appropriate analytic technique.
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768The development of accurate automated contour
etection algorithms remains a challenging issue,
nd significant user interaction is still required to
nsure consistently accurate TICs—especially when
oor breatholding results in cardiac motion. Further-
ore, calculation of AMBF requires specialized com-
utational software to obtain the transfer function
rom the LV and myocardial TICs. Software capable
f automatic AMBF calculation will be necessary for
his technique to move beyond the research realm.
onclusions
MBF can be calculated by mathematical mod-
Figure 4. Transmural Gradient in Flow Measured by CMR-PI
The relative gradient in ﬂow from endocardium to epicardium was
in a dog during adenosine vasodilation with a severe stenosis of th
anteroseptum and inferolateral wall over time resembles the M-mo
2-voxel increments demonstrate a progressive reduction in ﬂow fro
relatively uniform ﬂow in the anteroseptal remote zone. Reprinted
 left ventricle; RV  right ventricle.ity, correlation to flow, and suscepti- hri AF, Nandalurate than semiquantitative or qualitative methods
or identifying hemodynamically significant cor-
nary artery stenoses in experimental models and
atients with suspected CAD. The ability to
etect global reductions in perfusion reserve,
ssess serial changes in flow with improved pre-
ision, and examine subendocardial flow can pro-
ide important insights to our understanding of
he pathophysiology of myocardial disease and
id in the evaluation of novel therapies.
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